NL-OMON43240已完成不适用
PreventIT enhanced Lifestyle-integrated Functional Exercise programme pilot study - PreventIT eLiFE pilot study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •We will include community dwelling adults between 60 and 70 years of age. Only participants with ability to walk 500 metres without walking aids will be included.
排除标准
- •Exclusion criteria include cognitive impairment (Montreal Cognitive Assessment, MOCA *24 points) and self-reported cardiovascular, pulmonary, neurological, and mental disease where exercise is contraindicated, any changes in health condition the past 6 months (stroke, cancer in need of treatment, severe neurological diseases that affect physical function, COPD (Gold 3 and 4), and heart failure (NYHA 3 and 4)). The target population of eLiFE is not the most fit of the young older adults. Excluded are therefore those who are attending organised exercise classes more than twice a week and/or those who are exercising more than 1 hour on their own each week.
研究者
相似试验
已完成
不适用
PreventIT adapted Lifestyle-integrated Functional Exercise Program Pilot studyGeriatrische aandoeningen, functieverliesgerontologyold ageNL-OMON43547Interne geneeskunde, sectie ouderengeneeskunde10
已完成
不适用
Tailoring an existing lifestyle intervention to improve components of the metabolic syndrome in individuals with low SES from different ethnic originsCardiovasculaire risicofactorenAbdominal obesityoverweightNL-OMON36980Wageningen Universiteit252
已完成
不适用
Multidisciplinary Lifestyle-enhancing Treatment for long-term severe mentally ill Inpatients: Sheltered HousingNL-OMON46233GGZ Centraal (Amersfoort)168
尚未招募
不适用
A combined lifestyle intervention delivered by physio/exercise therapists for patients with persistent low back pain and overweight or obesity: a randomized controlled trial with parallel economic evaluatioLow back pain10023213sciaticaNL-OMON56872Vrije Universiteit318
尚未招募
不适用
Digital, blended lifestyle intervention program for remission and improved management of type 2 diabetes10018424DiabetesNL-OMON51256Ancora Health BV410